{
  "id": 6476292,
  "title": "Tyra disappoints investors with bladder cancer data",
  "url": "https://urgent.news/2026/09/09/tyra-disappoints-investors-with-bladder-cancer-data",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-09T19:46:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/tyra-bladder-cancer-dabogratinib-study-results/829917/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Remission rates observed in a Phase 2 trial fell short of Wall Street's expectations, though some analysts believe the company should see better results in late-stage testing.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}